Base-modified thymidines capable of terminating DNA synthesis are novel bioactive compounds with activity in cancer cells.
Borland KM, AbdulSalam SF, Solivio MJ, Burke MP, Wolfkiel PR, Lawson SM, Stockman CA, Andersen JM, Smith S, Tolstolutskaya JN, Gurjar PN, Bercz AP, Merino EJ, Litosh VA.
Borland KM, et al. Among authors: abdulsalam sf.
Bioorg Med Chem. 2015 Apr 15;23(8):1869-81. doi: 10.1016/j.bmc.2015.01.057. Epub 2015 Feb 14.
Bioorg Med Chem. 2015.
PMID: 25778768
Free PMC article.